News in brief - April 2014 (updated)

Other new launches, licence changes and updates relevant to general practice.

Diafer may be administered at a dose of up to 200mg, with a maximum weekly dosage of 1g.
Diafer may be administered at a dose of up to 200mg, with a maximum weekly dosage of 1g.
  • Diafer is a new injectable formulation of iron (as iron [III] isomaltoside 1000) for the treatment of iron deficiency in adults with chronic kidney disease who are on dialysis.
  • The quadrivalent HPV vaccine Gardasil can now be administered in a two-dose schedule in children aged nine to 13 years. The previously recommended three-dose schedule remains an option.
  • HyQvia is a new human normal immunoglobulin product which contains hyaluronidase to facilitate absorption of the immunoglobulin, allowing it to be administered by subcutaneous injection every 3-4 weeks.
  • Aquoral spray, used for the relief of dry mouth, has been renamed Aequasyal.
  • A new oral solution formulation of tapentadol (Palexia) has been launched for the relief of moderate to severe acute pain inadequately controlled with opioid analgesics.
  • Jentadueto (linagliptin/metformin) can now be used in combination with insulin for type II diabetes, when insulin plus metformin is inadequate. Prescribers should consider reducing the previous dose of insulin to reduce the risk of hypoglycaemia.
  • Praxilene (naftidrofuryl) is no longer licensed for the treatment of cerebral vascular disorders. It is still approved for peripheral vascular disorders.
  • The MHRA has highlighted the theoretical potential for orlistat to reduce the efficacy of antiretrovirals. Orlistat, whether prescribed or obtained without a prescription under the supervision of a pharmacist, should only be initiated after careful consideration of the potential impact on the efficacy of the antiretroviral regimen.

Follow MIMS on Twitter

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

A woman wearing a white vest as a blue-gloved hand of a healthcare professional are seen injecting a vaccine.

'Nocebo' effect may cause two-thirds of COVID-19 vaccine reactions, study suggests

Two-thirds of adverse reactions reported with the COVID-19...

An elderly woman with one arm in a plaster cast sits resting both hands on her walker

Doctors urge NICE to reverse decision on new osteoporosis drug

More than NHS 100 clinicians have called on NICE to...

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Image of both strengths of Seffalair Spiromax inhaler side by side.

New salmeterol/fluticasone dry powder inhaler for asthma

Seffalair Spiromax is the sixth dry powder salmeterol/fluticasone...